Ichiro Iwanaga

Technical difficulty according to location, and risk factors for perforation, in endoscopic submucosal dissection of colorectal tumors

Takeshi Mizushima, Mototsugu Kato, Ichiro Iwanaga et al. · Surgical Endoscopy · 2014 · 99 citations

Medicine, Oncology, Surgery +13

S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial

Yasuhide Yamada, Tadamichi Denda, Makio Gamoh et al. · Annals of Oncology · 2017 · 91 citations · Full text

Medicine, Oncology, Pharmacology +10

Randomized Controlled Trial on the Skin Toxicity of Panitumumab in Japanese Patients with Metastatic Colorectal Cancer: HGCSG1001 Study; J-STEPP

Yoshimitsu Kobayashi, Yoshito Komatsu, Satoshi Yuki et al. · Future Oncology · 2015 · 85 citations

Medicine, Oncology, Pharmacology +15

Open‐label, randomized, comparative, phase <scp>III</scp> study on effects of reducing steroid use in combination with Palonosetron

Yoshito Komatsu, Kenji Okita, Satoshi Yuki et al. · Cancer Science · 2015 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II Study of Combined Treatment with Irinotecan and S-1 (IRIS) in Patients with Inoperable or Recurrent Advanced Colorectal Cancer (HGCSG0302)

Yoshito Komatsu, Satoshi Yuki, Susumu Sogabe et al. · Oncology · 2011 · 26 citations

Medicine, Oncology, Pharmacology +13